MBIO has been in the news 900% more than usual
Jun 18, 2024, 4:32 PM
-59.96%
What does MBIO do
Mustang Bio, Inc., a clinical-stage biopharmaceutical company based in Worcester, Massachusetts, specializes in developing cell and gene therapies for hematologic cancers, solid tumors, and rare genetic diseases. The company, which went public in 2017, collaborates with notable medical centers like City of Hope and Fred Hutchinson Cancer Center to advance its CAR T therapy pipeline targeting various cancer markers.
MBIO has been in the news recently: Mustang Bio Inc (MBIO) shares are up significantly with high trading volume of 90 million, compared to the average of 3.17 million. Ovid Therapeutics Inc shares dropped by 65.7% to $1.1285 due to disappointing results from Takeda's Skyline study in Dravet syndrome.
📡️ Health Care
In The News
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.